First Medical Long-Term Care Social Responsibility Case: Hsing Yeh Biotech Signs NT$5.3 Billion Syndicated Loan
Taipei Fubon Bank and First Commercial Bank announced today that Hsing Yeh Biotech, a subsidiary of Cheng Ye Biomedical Group, has officially signed a NT$5.3 billion social responsibility syndicated loan agreement. This marks Taiwan's first medical and long-term care social responsibility loan case, funding the construction of Hsing Lin Hospital and Cheng Ye Long-Term Care Park in Taoyuan Yangmei.
📋 Article Processing Timeline
- 📰 Published: May 8, 2026 at 13:42
- 🔍 Collected: May 8, 2026 at 14:01 (19 min after Published)
- 🤖 AI Analyzed: May 9, 2026 at 01:19 (11h 17m after Collected)
Taipei, May 8 (CNA) Taipei Fubon Bank and First Commercial Bank announced today that Hsing Yeh Biotech, a subsidiary of Cheng Ye Biomedical Group, has officially signed a NT$5.3 billion social responsibility syndicated loan agreement. This marks Taiwan's first medical and long-term care social responsibility loan case.
Taipei Fubon Bank stated that the case was led by Taipei Fubon Bank as the collateral management bank and social responsibility loan coordinator, and First Commercial Bank as the credit line management bank. With the enthusiastic participation of four other banks—Chang Hwa Bank, Hua Nan Bank, Taishin Bank, and Cooperative Bank—the fundraising was successfully completed with an oversubscription rate of 120%, demonstrating the syndicated loan group's support and affirmation for Cheng Ye Biomedical's commitment to Taiwan's long-term care business.
First Commercial Bank explained that the syndicated loan funds will primarily support Hsing Yeh Biotech in constructing Hsing Lin Hospital and Cheng Ye Long-Term Care Park in Taoyuan Yangmei, which will focus on orthopedics, rehabilitation, and geriatric medicine. The project is expected to be completed and operational in 2029, and is anticipated to become a benchmark "medical-nursing integration" demonstration base in northern Taiwan, strengthening regional medical capacity and improving the quality of care in an aging society, thus serving a social welfare purpose.
First Commercial Bank stated that in addition to the steady development of Cheng Ye Biomedical Group's existing high-end medical device business and record-high revenue growth in pharmaceutical channels, several years ago, it also partnered with Japan's long-term care brand Sakura Juji Group to establish a joint venture, jointly planning long-term care businesses in Taiwan. Furthermore, its subsidiary "Fukang Chain Pharmacy" has achieved逆勢成長 (counter-trend growth) in a generally slowing pharmacy industry. The group's cumulative revenue for the first three months of this year reached NT$1.16 billion, a year-on-year increase of 15.49%.
Taipei Fubon Bank pointed out that unlike existing cases in the syndicated loan market that focus on a single hospital, this case combines a hospital with long-term care institutions, with services spanning both medical and care systems. Compared to general hospitals, long-term care institutions involve diverse revenue sources such as government subsidies, self-paid services, and referrals from medical systems, making their operational structure and cash flow patterns more complex. This presents certain challenges in credit assessment, risk measurement, and communication with the syndicated loan group. (Editor: Yang Lan-hsuan) 1150508
Stand with the facts, your every sponsorship is the power to protect press freedom.
Download CNA's "First-hand News" APP to stay updated with the latest news.
The text, images, and videos on this website may not be reproduced, publicly broadcast, or publicly transmitted and used without authorization.
Taipei Fubon Bank stated that the case was led by Taipei Fubon Bank as the collateral management bank and social responsibility loan coordinator, and First Commercial Bank as the credit line management bank. With the enthusiastic participation of four other banks—Chang Hwa Bank, Hua Nan Bank, Taishin Bank, and Cooperative Bank—the fundraising was successfully completed with an oversubscription rate of 120%, demonstrating the syndicated loan group's support and affirmation for Cheng Ye Biomedical's commitment to Taiwan's long-term care business.
First Commercial Bank explained that the syndicated loan funds will primarily support Hsing Yeh Biotech in constructing Hsing Lin Hospital and Cheng Ye Long-Term Care Park in Taoyuan Yangmei, which will focus on orthopedics, rehabilitation, and geriatric medicine. The project is expected to be completed and operational in 2029, and is anticipated to become a benchmark "medical-nursing integration" demonstration base in northern Taiwan, strengthening regional medical capacity and improving the quality of care in an aging society, thus serving a social welfare purpose.
First Commercial Bank stated that in addition to the steady development of Cheng Ye Biomedical Group's existing high-end medical device business and record-high revenue growth in pharmaceutical channels, several years ago, it also partnered with Japan's long-term care brand Sakura Juji Group to establish a joint venture, jointly planning long-term care businesses in Taiwan. Furthermore, its subsidiary "Fukang Chain Pharmacy" has achieved逆勢成長 (counter-trend growth) in a generally slowing pharmacy industry. The group's cumulative revenue for the first three months of this year reached NT$1.16 billion, a year-on-year increase of 15.49%.
Taipei Fubon Bank pointed out that unlike existing cases in the syndicated loan market that focus on a single hospital, this case combines a hospital with long-term care institutions, with services spanning both medical and care systems. Compared to general hospitals, long-term care institutions involve diverse revenue sources such as government subsidies, self-paid services, and referrals from medical systems, making their operational structure and cash flow patterns more complex. This presents certain challenges in credit assessment, risk measurement, and communication with the syndicated loan group. (Editor: Yang Lan-hsuan) 1150508
Stand with the facts, your every sponsorship is the power to protect press freedom.
Download CNA's "First-hand News" APP to stay updated with the latest news.
The text, images, and videos on this website may not be reproduced, publicly broadcast, or publicly transmitted and used without authorization.